ArticlePatient preference and adherence2026
Polypharmacy Experience of Middle-Aged and Elderly Patients with Type 2 Diabetes Comorbidity: A Qualitative Study.
Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To reveal the real experience of polypharmacy in middle-aged and elderly patients with type 2 diabetes comorbidity, based on the Common-Sense Model of self-regulation (CSM). Patients and Methods: With the method of purposive sampling, 15 middle-aged and elderly patients with type 2 diabetes comorbidity hospitalized in the endocrinology department of a tertiary hospital were selected for semi-structured interviews. Using the Colaizzi's seven-step method to analyze and organize the interview results. Results: 4 themes and 9 subthemes were identified and organized based on the Common-Sense Model of self-regulation: cognitive representation (cognitive struggle in coexistence with medicines, physical discomfort and adjustment, expectations for treatment methods); emotional representation (memory burden, space management burden); coping strategies - negative and positive responses (negative emotions related to polypharmacy, self driven); external factors (family support feels helpful, medical staff support feels relieved). Conclusion: The psychological experience of middle-aged and elderly patients with type 2 diabetes comorbidity in the course of taking medicine includes the interaction of cognitive and emotional representation, coping strategies and external support system at all levels. Medical personnel should clarify patients' treatment burden, polypharmacy burden, self-management workload, coping strategies and effective support system during the medication process, in order to provide patient-centered medicine care and achieve more ideal emotional and health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.